Screener
Ginkgo Bioworks DNA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's retained earnings?
- Ginkgo Bioworks (DNA) reported retained earnings of -$6.28B in Q2 2026.
- How has Ginkgo Bioworks's retained earnings changed year-over-year?
- Ginkgo Bioworks's retained earnings decreased by 4.9% year-over-year, from -$5.99B to -$6.28B.
- What is the long-term trend for Ginkgo Bioworks's retained earnings?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's retained earnings has grown at a 67.4% compound annual growth rate (CAGR), from -$467.88M to -$6.15B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Ginkgo Bioworks's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude